- 09 April 2024 22:46:12
- Source: Sharecast
Publication of Supplementary Prospectus
The following Supplementary Prospectus has been approved by the Financial Conduct Authority and is available for viewing:
Supplementary Prospectus dated 9 April 2024 (the "Supplementary Prospectus") relating to the £25,000,000,000 Euro Medium Term Note Programme of B.A.T. International Finance p.l.c., B.A.T Capital Corporation and B.A.T. Netherlands Finance B.V. (as Issuers) and British American Tobacco p.l.c. and each of the Issuers (except where it is the relevant Issuer) (as Guarantors).
The Supplementary Prospectus should be read and construed in conjunction with the Base Prospectus dated 5 March 2024, as supplemented by the supplementary prospectus dated 28 March 2024 (together, the "Prospectus").
To view the Supplementary Prospectus, please paste the following URL into the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/8661J_1-2024-4-9.pdf
The full document will be submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
Enquiries
British American Tobacco Press Office
+44 (0)20 7845 2888 (24 hours) │@BATPlc
British American Tobacco Investor Relations
Victoria Buxton / Amy Chamberlain / Yetunde Ibe / John Harney / Jane Henderson
+44 (0)20 7845 2012 / 1124 / 1095 / 1263 / 1117
British American Tobacco p.l.c.
Globe House
4 Temple Place
London WC2R 2PG
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus, you must ascertain from the Prospectus whether or not you are one of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above requirement.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
